Biotech Essentials

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 08.12.2020.

#BioTech
#COVID19
#coronavirus
#cancer
#stocks
#healthcare
#NBTintheNews
#BioTechnology

Healthcare

@MattHancock shared
On Dec 5, 2020
I’m delighted that over half a million people have now taken part in #coronavirus research across the UK. I want to thank every single person who has taken part in this research. https://t.co/ra09f87noj
Open
Over half a million people taking part in pioneering COVID-19 research

Over half a million people taking part in pioneering COVID-19 research

637,379 participants from across the UK have now taken part in public health research into the effects of, and treatment for, COVID-19 in just over 8 months.

@SWLifeSciences shared
On Dec 2, 2020
Biotech Licenses Platform for Faster Pathway for Cancer and COVID-19 Vaccine Trial: https://t.co/DbWUBhq4sh The rationale behind OncoSec Medical using this system is discussed in a Dawson James report. $ONCS #covid19 #healthcare #cancer #biotech #stocks @OncoSec https://t.co/YZALR9dVi1
Open
Biotech Licenses Platform for Faster Pathway for Cancer and COVID-19 Vaccine Trials Research Report

Biotech Licenses Platform for Faster Pathway for Cancer and COVID-19 Vaccine Trials Research Report

The rationale behind OncoSec Medical using this system is discussed in a Dawson James report.

@BiotechSweden shared
On Dec 3, 2020
Biotech Licenses Platform for Faster Pathway for Cancer and COVID-19 Vaccine Trials #BioTech via https://t.co/2sI0UxJbpn https://t.co/f39a77tMrD
Open
Biotech Licenses Platform for Faster Pathway for Cancer and COVID-19 Vaccine Trials

Biotech Licenses Platform for Faster Pathway for Cancer and COVID-19 Vaccine Trials

In a Nov. 25 research note, Dawson James analyst Jason Kolbert reported that OncoSec Medical Inc. (ONCS:NASDAQ) licensed the rights to the Cliniporator gene delivery platform and …

@NatureBiotech shared
On Dec 4, 2020
Viral clearance in the manufacture of biologics #NBTintheNews via @GENbio https://t.co/ycehaQq1C6
Open
Viral Clearance in the Manufacture of Biologics

Viral Clearance in the Manufacture of Biologics

Bioprocessors have had a good handle on viral safety, but they need to keep their grip as they shift toward continuous processing and boost production of gene and cell therapies.

@BiotechSweden shared
On Dec 7, 2020
COVID Vaccine: Bharat Biotech Seeks Emergency Use Nod For Covaxin #BioTech via https://t.co/2sI0UxJbpn https://t.co/u6ZzYLaG38
Open
COVID Vaccine: Bharat Biotech Seeks Emergency Use Nod For Covaxin

COVID Vaccine: Bharat Biotech Seeks Emergency Use Nod For Covaxin

Bharat Biotech on Monday filed an application with the Drugs Controller General of India (DCGI) for emergency use authorisation of its Covid-19 vaccine- Covaxin

@BiotechSweden shared
On Dec 7, 2020
Bharat Biotech seeks emergency authorization of Covaxin; CDSCO to review applications soon #BioTech via https://t.co/2sI0UxJbpn https://t.co/4pjn9pjYZw
Open
Bharat Biotech Seeks Emergency Authorization Of Covaxin; CDSCO To Review Applications Soon

Bharat Biotech Seeks Emergency Authorization Of Covaxin; CDSCO To Review Applications Soon

In a major boost to India's race for the COVID-19 vaccine, Bharat Biotech has sought emergency use authorization for its COVID-19 vaccine candidate - Covaxin

@BiotechSweden shared
On Dec 5, 2020
Kerala to home Biotechnology centre named after Guruji Golwalkar #BioTechnology #biotech via https://t.co/2sI0UxJbpn https://t.co/rRf5QjRr6E
Open
Kerala to home Biotechnology centre named after Guruji Golwalkar

Kerala to home Biotechnology centre named after Guruji Golwalkar

     Union Minister for Science and Technology Dr Harsh Vardhan while attending a virtual conference on Friday said that the second campus of Rajiv Gandhi Centre for Biotechnology (RGCB) ...

@BiotechSweden shared
On Dec 7, 2020
Bharat Biotech files for emergency use of Covaxin #BioTech via https://t.co/2sI0UxJbpn https://t.co/i5mjleOMRI
Open
COVID-19 vaccine update: Bharat Biotech files for emergency use of Covaxin

COVID-19 vaccine update: Bharat Biotech files for emergency use of Covaxin

After American drug maker Pfizer and Pune-based Serum Institute, Bharat Biotech is the third company to apply for emergency use authorisation for its COVID-19 vaccine to the DCGI